Experienced in Plasmacytoma

Dr. Eric W. Dean

Oncology | Hematology
The Association Of University Physicians
825 Eastlake Ave E, 
Seattle, WA 
Accepting New Patients
Offers Telehealth
Experienced in Plasmacytoma
The Association Of University Physicians
825 Eastlake Ave E, 
Seattle, WA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Eric Dean is an Oncologist and a Hematologist in Seattle, Washington. Dr. Dean is rated as an Experienced provider by MediFind in the treatment of Plasmacytoma. His top areas of expertise are Large-Cell Immunoblastic Lymphoma, Pleuropulmonary Blastoma, Lung Cancer, and Small Cell Lung Cancer (SCLC). Dr. Dean is currently accepting new patients.

His clinical research consists of co-authoring 3 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Oncology
Hematology
Licenses
Internal Medicine in WA
Hospital Affiliations
Evergreenhealth Monroe
University Of Washington Medical Ctr
Evergreenhealth Medical Center
Languages Spoken
English
Bengali
Filipino
German
Hindi
Spanish
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Community Health
  • EPO
  • HMO
Coordinated Care
  • HMO
  • MANAGED MEDICAID PLAN
Group Health Cooperative
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Lifewise

Accepted plan types not found. Please verify directly with the provider.

Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
PacificSource
  • PPO
Premera
  • EPO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 15 Less Insurance Carriers -

Locations

THE ASSOCIATION OF UNIVERSITY PHYSICIANS
825 Eastlake Ave E, Seattle, WA 98109

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Phase III Randomized Adjuvant Study of Pembrolizumab in muScle invaSive and locAlly aDvanced urOthelial caRcinoma (AMBASSADOR) Versus Observation
Phase III Randomized Adjuvant Study of Pembrolizumab in muScle invaSive and locAlly aDvanced urOthelial caRcinoma (AMBASSADOR) Versus Observation
Enrollment Status: Active_not_recruiting
Publish Date: October 09, 2025
Intervention Type: Other, Biological, Procedure
Study Drug: Pembrolizumab
Study Phase: Phase 3
Adjuvant Nivolumab in Resected Lung Cancers (ANVIL)-A Randomized Phase III Study of Nivolumab After Surgical Resection and Adjuvant Chemotherapy in Non-Small Cell Lung Cancers
Adjuvant Nivolumab in Resected Lung Cancers (ANVIL)-A Randomized Phase III Study of Nivolumab After Surgical Resection and Adjuvant Chemotherapy in Non-Small Cell Lung Cancers
Enrollment Status: Active_not_recruiting
Publish Date: September 22, 2025
Intervention Type: Procedure, Biological, Other
Study Drug: Nivolumab
Study Phase: Phase 3
Phase III Randomized Trial of Concurrent Chemoradiotherapy With or Without Atezolizumab in Localized Muscle Invasive Bladder Cancer
Phase III Randomized Trial of Concurrent Chemoradiotherapy With or Without Atezolizumab in Localized Muscle Invasive Bladder Cancer
Enrollment Status: Active_not_recruiting
Publish Date: September 03, 2025
Intervention Type: Other, Procedure, Drug, Radiation
Study Drugs: Atezolizumab, Cisplatin, Fluorouracil, Gemcitabine, Mitomycin C
Study Phase: Phase 3
Phase II Study of Lenalidomide and Rituximab in Subjects with Previously Untreated Indolent Non Hodgkin's Lymphoma
Phase II Study of Lenalidomide and Rituximab in Subjects with Previously Untreated Indolent Non Hodgkin's Lymphoma
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Drug
Study Drugs: Rituximab, Lenalidomide
Study Phase: Phase 2
View 3 Less Clinical Trials

3 Total Publications

Corrigendum: Genome-wide association study identifies variants at 16p13 associated with survival in multiple myeloma patients.
Corrigendum: Genome-wide association study identifies variants at 16p13 associated with survival in multiple myeloma patients.
Journal: Nature communications
Published: December 10, 2015
Similar Doctors
Advanced in Plasmacytoma
Dr. Andrew J. Cowan
Hematology Oncology | Hematology | Oncology
Advanced in Plasmacytoma
Dr. Andrew J. Cowan
Hematology Oncology | Hematology | Oncology

The Association Of University Physicians

825 Eastlake Ave E, 
Seattle, WA 
 (0.1 miles away)
206-288-1000
Languages Spoken:
English, Filipino, Hindi, Punjabi, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Andrew Cowan is a Hematologist Oncology specialist and a Hematologist in Seattle, Washington. Dr. Cowan is rated as an Advanced provider by MediFind in the treatment of Plasmacytoma. His top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, and Schnitzler Syndrome. Dr. Cowan is currently accepting new patients.

Advanced in Plasmacytoma
Dr. Mary L. Kwok
Hematology Oncology | Hematology | Oncology
Advanced in Plasmacytoma
Dr. Mary L. Kwok
Hematology Oncology | Hematology | Oncology

The Association Of University Physicians

825 Eastlake Ave E, 
Seattle, WA 
 (0.1 miles away)
206-288-1000
Languages Spoken:
English, Arabic, Korean, Mandarin
See accepted insurances
Accepting New Patients
Offers Telehealth

Mary Kwok is a Hematologist Oncology specialist and a Hematologist in Seattle, Washington. Dr. Kwok is rated as a Distinguished provider by MediFind in the treatment of Plasmacytoma. Her top areas of expertise are Smoldering Multiple Myeloma, Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Waldenstrom Macroglobulinemia. Dr. Kwok is currently accepting new patients.

Advanced in Plasmacytoma
Dr. Anuradha A. Belur
Hematology Oncology | Hematology | Oncology
Advanced in Plasmacytoma
Dr. Anuradha A. Belur
Hematology Oncology | Hematology | Oncology

Multicare Health System

222 State Ave N, 
Kent, WA 
 (17.5 miles away)
253-372-7788
Languages Spoken:
English, Castilian, Filipino, Hindi, Kannada, Spanish, Urdu
See accepted insurances
Accepting New Patients
Offers Telehealth

Anuradha Belur is a Hematologist Oncology specialist and a Hematologist in Kent, Washington. Dr. Belur is rated as a Distinguished provider by MediFind in the treatment of Plasmacytoma. Her top areas of expertise are Paget Disease of the Breast, Angiosarcoma, Inflammatory Breast Cancer, and Multiple Myeloma. Dr. Belur is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Dean's expertise for a condition
ConditionClose
      View All 24 Advanced Conditions
      View All 80 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile